ORBi: Scheen André - Addition of incretin therapy to metformin in type 2 diabetes.

Reference : Addition of incretin therapy to metformin in type 2 diabetes.


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology Human health sciences : Endocrinology, metabolism & nutrition
	To cite this reference:	http://hdl.handle.net/2268/56416

Title :	Addition of incretin therapy to metformin in type 2 diabetes.
Language :	English
Author, co-author :	Scheen, André [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
	Radermecker, Régis [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Publication date :	2010
Journal title :	Lancet
Publisher :	Lancet Publishing Group
Volume :	375
Issue/season :	9724
Pages :	1410-2
Audience :	International
ISSN :	0140-6736
e-ISSN :	1474-547X
City :	London
Country :	United Kingdom
Keywords :	[en] incretin ; metformin ; type 2 diabetes
Target :	Researchers ; Professionals
Permalink :	http://hdl.handle.net/2268/56416
DOI :	10.1016/S0140-6736(10)60399-6
Other URL :	http://www.thelancet.com

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	Addition%20of%20incretin%20therapy%20to%20metformin%20in%20type%202%20%20diabetes[_ocr.pdf		Author postprint	116.67 kB	View/Open

All documents in ORBi are protected by a user license.